Effect of the new preventive medicine on cisplatin-induced acute kidney injury
Mitsuhiro Goda(Okayama University), Keisuke Ishizawa(Tokushima University Hospital), Kazuhito Saike(Tokushima University), Takahiro Niimura(Tokushima University), Hirofumi Hamano(Tokushima University Hospital), Naoto Okada(Yamaguchi University Hospital), Masaya Kanda(Tokushima University Hospital), Yuki Izawa‐Ishizawa(Shikoku University), Yasumasa Ikeda(Tokushima University), Yoichi Murai(Tokushima University), Yuya Horinouchi(Tokushima University), Masayuki Chuma(Nihon University), Ami Yoshida(Tokushima University), Kenshi Takechi(Matsuyama University), Kenji Ikuta(Nagoya City University), Yoshito Zamami(Tokushima University Hospital)
Proceedings for Annual Meeting of The Japanese Pharmacological Society
January 1, 2019
Cited by 0
Related Papers
Estrogen Regulates Hepcidin Expression via GPR30-BMP6-Dependent Signaling in Hepatocytes
|PLoS ONE|2012|138
Factors Associated With Immune Checkpoint Inhibitor–Related Myocarditis
|JAMA Oncology|2019|134
Association Between Immune-Related Adverse Events and Clinical Efficacy in Patients with Melanoma Treated With Nivolumab: A Multicenter Retrospective Study
|Clinical Therapeutics|2018|99
Iron Chelation by Deferoxamine Prevents Renal Interstitial Fibrosis in Mice with Unilateral Ureteral Obstruction
|PLoS ONE|2014|94
Royal Jelly Ameliorates Insulin Resistance in Fructose-Drinking Rats
|Biological and Pharmaceutical Bulletin|2008|88